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An acidic microenvironment has been shown to evoke a variety of airway responses, including cough, bronchoconstriction, airway
hyperresponsiveness (AHR), infiltration of inflammatory cells in the lung, and stimulation of mucus hyperproduction. Except
for the participation of transient receptor potential vanilloid-1 (TRPV1) and acid-sensing ion channels (ASICs) in severe acidic
pH (of less than 6.0)-induced cough and bronchoconstriction through sensory neurons, the molecular mechanisms underlying
extracellular acidic pH-induced actions in the airways have not been fully understood. Recent studies have revealed that ovarian
cancer G protein-coupled receptor 1 (OGR1)-family G protein-coupled receptors, which sense pH ofmore than 6.0, are expressed in
structural cells, such as airway smooth muscle cells and epithelial cells, and in inflammatory and immune cells, such as eosinophils
and dendritic cells.They function in a variety of airway responses related to the pathophysiology of inflammatory diseases, including
allergic asthma. In the present review, we discuss the roles of ionotropic TRPV1 and ASICs and metabotropic OGR1-family G
protein-coupled receptors in the airway inflammation and AHR in asthma and respiratory diseases.
1. Introduction
Airway acidification has been shown to be attained by either
the exogenous way, that is, the microaspiration of acid
contents into the airway during gastroesophageal reflux and
inhalation of low pH pollutant aerosol, or the endogenous
way, that is, ischemia and inflammation of the airways in
inflammatory diseases, such as asthma, cystic fibrosis, and
chronic obstructive pulmonary disease (COPD) [1–3]. In
ischemic and inflammatory situations, the stimulation of
anaerobic glycolysis causes lactate production. In patients
with asthma, it has been reported that airway pH reaches 5.2
to 7.1, depending on the severity: pH is normalizedwith corti-
costeroid therapy [1]. Although alteration of airway pH may
serve an innate host defense capacity, that is, inhibiting the
survival of bacteria in an acidic environment, it is also impli-
cated in the pathophysiology of obstructive airway diseases.
Thus, exposure to acids evokes a cough, bronchoconstriction,
airway hyperreactivity (AHR), and microvascular leakage
and stimulates mucus production [2]. However, molecular
mechanisms underlying the extracellular acidic pH-induced
actions in the airways have not been fully understood.
In the present review, we discuss the proton-sensing mecha-
nisms, focusing on proton-sensing ionotropic receptors, such
as transient receptor potential vanilloid-1 (TRPV1) and acid-
sensing ion channels (ASICs), andmetabotropic ovarian can-
cer G protein-coupled receptor 1 (OGR1)-family G protein-
coupled receptors (GPCRs), in the airway inflammation and




The mammalian transient receptor potential (TRP) super-
family of nonselective cation channels encompasses 28 iso-
types and is divided into six subfamilies, that is, TRPC,
TRPV, TRPM, TRPA, TRPP, and TRPML. These channels
are expressed in neurons and a wide range of cell types
in many biological systems [4–6]. TRP channels have six
putative transmembrane domains and a pore-forming loop
between the fifth and sixth segments. They are thought to be
composed of homo- or heterotetramers [5]. Among them,
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capsaicin-sensitive TRPV1 is activated by a diverse range
of chemical and noxious stimuli, including protons [5–7].
TRPV1 senses relatively strong acidic pH of 4 to 5 through
glutamic acid in the extracellular domain of the channel
[7] (Figure 1). TRP channels other than TRPV1, including
TRPA1, TRPV4, and TRPM8, are expressed in the respiratory
system and involved in the regulation of airway functions
[8–10]; however, whether protons practically trigger their
channel activation remains unknown.
Another important family of proton-sensing channel is
ASIC. ASICs are proposed to assemble as tetramers with
homomeric or heteromeric subunits; each subunit consists
of two transmembrane domains [11] (Figure 1). Six ASIC
subunit proteins, encoded by four genes, have been identified:
ASIC1a, ASIC1b, ASIC2a, ASIC2b, ASIC3, and ASIC4. ASICs
are voltage-independent channels that mainly conduct Na+
[12]. Recent studies have demonstrated that ASICs activated
by acidic pH play an important role in a wide range of physio-
logical and pathophysiological processes such as nociception,
mechanosensation, synaptic plasticity, and acidosis-mediated
neuronal injury [11]. Histidine, glutamic acid, and aspartic
acid may determine a broad range of optical pH of 4 to 7 for
activation, depending on the subtypes [4, 13, 14]. Some forms
of ASIC mRNAs have been detected in pulmonary sensory
neurons [6].
In addition to TRPV1 and ASICs, there is increasing
evidence that further acid-sensitive ion channels are involved
in monitoring acidosis. These include TRP family ion chan-
nels other than TRPV1, including TRPV4, TRPC4, TRPC5,
and TRPP2 (PKD2L1); two-pore domain K+ (K
2p) channels;
ionotropic purinoceptors (P2X); inward rectifier K+ chan-
nels; voltage-activated K+ channels; L-type Ca2+ channels;
hyperpolarization-activated cyclic nucleotide gated channels;
gap junction channels; and Cl− channels [4]. Although most
of these channels seem to be expressed and play important
roles in the respiratory system, their extracellular proton-
sensitivity has not, to our knowledge, been demonstrated for
specific airway responses [10, 15–17].
Recent studies suggest that OGR1-family GPCRs, includ-
ing OGR1 (GPR68), GPR4, and T cell-death associated gene
8 (TDAG8 or GPR65), also sense extracellular protons and,
thereby, stimulates a variety of cellular activities through
several types of G proteins [18–21] (Figure 1). This receptor
family is expressed not only in neurons but also in nonneu-
ronal cells. OGR1-familyGPCRswere previously described as
GPCRs for lysolipids, such as sphingosylphosphorylcholine
[19–21]. Ludwig et al. [18], however, first discovered that
OGR1 and GPR4 sense extracellular protons and are coupled
to Gq and Gs, leading to activation of the phospholipase
C/Ca2+ signaling pathway and the adenylyl cyclase/cAMP
signaling pathway, respectively [18]. Later it was found that
TDAG8 similarly senses extracellular protons, leading to the
activation of the cAMP signaling pathway [22, 23]. OGR1-
family GPCRs sense weak acidic to weak alkaline pH of
6 to 8 through histidine residues [18, 19, 24, 25]. G2A is
also classified in this receptor family and is expressed by
a broad range of immunoregulatory cell types, including
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Figure 1: Ionotropic and metabotropic proton-sensing receptors.
Extracellular acidification evokes a variety of airway responses.
Ionotropic TRPV1 channel and ASICs mainly mediate severe acidic
pH-induced cough, pain, and bronchoconstriction through sensory
neurons, while OGR1-family GPCRs sense mild alkaline and mild
acidic pH and exert a wide range of cellular actions in many types of
structural and inflammatory cells.
and B cells, and it is suggested to play an important role
in innate and adaptive immunity [26]. However, the proton
sensitivity of the receptor is very small and its role as a
proton sensor has been questioned [27]. In the present review,
therefore, we do not focus further on G2A. OGR1-family
GPCRs are expressed in many cell types localized in the
airways, and the cases in which their roles are demonstrated
are summarized in Figure 2.
3. Role of Proton-Sensing Channels
and GPCRs in the Airways
3.1. Bronchoconstriction and AHR
3.1.1. Sensory Neurons. The proton-sensing TRPV1 channel
and/or ASICs in sensory nerves have first been proposed
to be involved in acidic pH-induced airway responses [2,
28, 29]. It has been established that TRPV1 on capsaicin-
sensitive primary sensory neurons plays an important role in
nociception and transmission of pain as a sensor of noxious
stimuli [2, 4, 30]. The activation of TRPV1 on the sensory
neurons by irritant compounds, including capsaicin and
citric acid, generates reflex responses that, in turn, stimulate
the release of tachykinins from the terminals of the sensory
nerves, causing cough and bronchoconstriction [2, 5, 29].
The possibility that the afferent signals and neuropeptide
release are coupled at the same nerve endings has also
been proposed [31]. The neurogenic role of TRPV1 was
based mainly upon experiments with selective agonists and
antagonists. For example, capsazepine, a TRPV1-selective
antagonist, and SR48968, a selectiveNK2 receptor antagonist,
blocked citric acid inhalation-induced bronchoconstriction
in guinea pig airways in vivo [32]. The role of TRPV1 in

















































Figure 2: Role of OGR1-family GPCRs inTh2 polarization and subsequent airway inflammation and AHR. See the text in detail.
AHR has recently been demonstrated by the finding that oral
administration of TRPV1-specific antagonists significantly
attenuated AHR in the asthma model of OVA-sensitized
guinea pigs [33]. In addition to TRPV1, involvement of
ASICs in acidic pH-induced AHR was suggested by using
selective ASIC inhibitors in the guinea pig tracheal rings ex
vivo [28]. These results suggest that bronchoconstriction and
AHR under acidic environments are indirectly mediated by
sensory neurons through proton-sensing channels, such as
TRPV1 and ASICs [6, 30]. In fact, no report has shown that
TRPV1 and ASICs are expressed and are directly functioning
in ASM cells, although vascular smooth muscle cells seem to
express TRPV1 [8] and ASICs [34].
3.1.2. Airway Smooth Muscle (ASM) Cells. The previous
studies, however, did not rule out the direct actions of
acidic pH on ASM cells. Ichimonji et al. [35] showed that
extracellular acidification stimulates mRNA expression and
protein production of IL-6, a proinflammatory cytokine, in
association with the phosphorylation of extracellular signal-
regulated kinase (ERK) and p38MAPK, in human ASM cells.
They also showed that extracellular acidification induced
an increase in intracellular Ca2+ concentration ([Ca2+]i)
[35], which was accompanied by ASM cell contraction
[36]. Acidification also induced expression of connective
tissue growth factor (CTGF), a critical factor involved in
the formation of extracellular matrix proteins and, hence,
airway remodeling. TGF-𝛽-induced CTGF expression was
also enhanced by acidic pH [37]. In ASM cells, OGR1 is
expressed at by far the highest levels among proton-sensing
GPCRs [35]. The knockdown of OGR1 and Gq with their
specific small interfering RNAs and an inhibition of Gq with
YM-254890 attenuated the acidification-induced actions [35,
37]. These results suggest that extracellular acidification
stimulates Ca2+ mobilization, inflammatory cytokine IL-6
and CTGF production, and contraction throughOGR1/Gq in
human ASM cells (Figure 2).
The role of OGR1 in AHR is supported by recent findings
with RGS2- [38] and RGS5-deficient mice [39]. RGS2 and
RGS5 are GTPase-activating proteins that inactivate Gq
stimulated by Gq-coupled receptors, including OGR1. Xie
et al. [38] showed that RGS2 deficiency caused spontaneous
AHR in response to methacholine without any prior antigen
sensitization/challenge. They also showed that the loss of
RGS2 augmented Ca2+ mobilization and the contraction of
ASM cells, increased ASM mass, and stimulated ASM cell
growth via ERK and phosphatidylinositol 3-kinase (PI3K)
pathways. These results are highly consistent with those of
in vitro studies with human ASM cells [35, 36]. Interestingly,
asthmapatients display lower expression of RGS2 in epithelial
cells and ASM cells in lung and circulating monocytes [38].
RGS5-deficient mice also showed spontaneous AHR, even
without antigen sensitization in association with enhanced
Ca2+mobilization, ERK activation, and ASM cell contraction
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[39]. In both cases, however, appreciable infiltration of
inflammatory cells in the lung and production of cytokines,
such as IL-4 and IL-5, was not observed [38, 39]. These
results suggest that T-cell activation is not always required for
GPCR-mediated asthma pathophysiology.
3.2. Mucus Hypersecretion in Epithelial Cells. Mucus hyper-
secretion is a common pathological feature of inflammatory
airway diseases, including asthma. Liu et al. [40] have
recently shown that an acidic pH of 6.4 stimulates mucin5AC
(MUC5AC) secretion in the human bronchial epithelial
cell line (16HBE) through the OGR1/Gq/phospholipase C
pathway (Figure 2). Knockdown of OGR1 and Gq expression
with small interfering RNAs inhibited acidification-induced
increases in [Ca2+]i and mucin production. Similarly, over-
expression of RGS2 protein attenuated acidic pH-induced
cellular responses, whereas knockdown of RGS2 slightly but
significantly enhanced these responses. These results suggest
that airway acidification induces mucin production through
the OGR1 and Gq, of which activation can be regulated
by RGS2. The same group has also shown that TRPV1 is
expressed and citric acid (pH 5.0)-induced mucin secretion
is mediated by Ca2+ influx via TRPV1 in the same cells
[41]. These results suggest that epithelial cells utilize different
proton-sensing machineries depending on the acidity of
microenvironments; OGR1-family GPCRs sense mild alka-
line to acidic pH of 8 to 6, whereas TRPV1 senses more acidic
pH of 6 to 4, as described above.
3.3. Leukocyte Adhesion to and Leakage through Endothelial
Cells. GPR4 has been shown to be expressed in endothelial
cells and to be activated by extracellular acidification, leading
to accumulation of cAMP, which may be relevant to normal
blood vessel formation [42]. Chen et al. have recently shown
that activation of GPR4 by acidosis increases endothelial
cell adhesion of monocytes in association with the expres-
sion of adhesion molecules, such as VCAM-1 and ICAM-1,
through the cAMP/Epac pathway [43]. Since VCAM-1 on the
endothelium has been shown tomediate eosinophil adhesion
and transmigration [44], this suggests that GPR4 is involved
in the perivascular accumulation of eosinophils in the lung
with inflammatory asthma (Figure 2). However, it remains
unknown whether GPR4 deficiency affects eosinophilia in
the airways with asthma.
3.4. Airway Eosinophilia due to Enhanced Survival of Eos-
inophils. Kottyan et al. [45] have reported that acidic pH
increased eosinophil viability due to an inhibition of apop-
tosis, which was associated with an increase in cAMP accu-
mulation. The acidic pH-induced increase in cell viability
was attenuated by the adenylyl cyclase inhibitor and, in
contrast, the phosphodiesterase inhibitor, the cell-permeable
cAMP analog, and forskolin mimicked the acidic pH effect.
The acidification-induced increase in eosinophil viability and
cAMP accumulation was completely lost in the cells isolated
from the TDAG8 knockout mice. These results suggest that
eosinophil viability is increased in acidic microenvironments
through the TDAG8/cAMPpathway (Figure 2).However, the
mechanism by which cAMP inhibits eosinophil apoptosis
remains unknown [45].
3.5. Cytokine and 𝑂
2
− Production in Macrophages and
Neutrophils. In macrophages, TDAG8 and OGR1 are
expressed. Extracellular acidification inhibited lipopolysac-
charide (LPS)-induced TNF-𝛼 and IL-6 protein and mRNA
production in mouse peritoneal macrophages [46]. The
inhibitory action on cytokine production by acidic pH
was significantly attenuated in macrophages from TDAG8-
deficient mice but not in those from OGR1-deficient
mice. Further characterization revealed that acidic pH
inhibited proinflammatory cytokine production through
the TDAG8/Gs/cAMP/PKA signaling pathway in mouse
macrophages. The expression of TDAG8 was increased by
glucocorticoid in the macrophage, which was associated
with the enhancement of acidification-induced inhibition of
TNF-𝛼 production [47].Thus, TDAG8 seems to be indirectly
involved in glucocorticoid-induced anti-inflammatory
actions.
Extracellular acidification has been shown to induce
human neutrophil activation, inducing an increase in [Ca2+]i,
a shape-changing response, upregulation of the expression





production [48]. These acidic pH-
induced responses are accompanied by the activation of
Akt and ERK. On the other hand, acidic pH has also been
shown to inhibit some neutrophil functions. Extracellular
acidic pH inhibits migration [49] and O
2
− production in
human neutrophils [50]. Although intracellular acidification
was supposed to, in part, explain the acidic pH-induced
actions [48, 50], the precise proton-sensing mechanisms
remained largely unknown. Murata et al. [51] have shown
that acidic pH inhibited fMLP- and C5a-induced superoxide
anion production. The acidic pH effect was mimicked by
cAMP increasing agents and attenuated by a PKA inhibitor.
Moreover, acidic pH increased cAMP accumulation. TDAG8
is coupled to cAMP signaling pathways and is abundantly
expressed in neutrophils.These data suggest that TDAG8may
mediate extracellular acidification-induced inhibition of O
2
−
production through cAMP [51].
Thus, TDAG8 is coupled to anti-inflammatory cAMP
signaling pathways in macrophages and neutrophils. Con-
sistently with an anti-inflammatory role, TDAG8-deficient
mice showed exacerbation of anti-type II collagen antibody-
induced arthritis, in which macrophages and neutrophils
have been shown to play a critical role [52]. However,
it remains uncharacterized whether the anti-inflammatory
actions of TDAG8 in macrophages and neutrophils are
involved in the pathophysiology of airway inflammation of
asthma.
3.6. T-Cell Priming and Polarization by Dendritic Cells.
Geffner and his colleagues have shown that extracellular
acidification (pH 6.5) stimulates internalization of antigens;
upregulated the expression of cell surface proteins, includ-
ing CD11c, MHC class II, CD40, and CD86, involved in
antigen presentation; and promoted an efficient MHC class
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I-restricted presentation of antigen peptides in dendritic
cells (DCs) of C57BL/6 mice [53]. Antigen-pulsed DCs
under acidic pH showed an improved efficacy for inducing
both specific CD8+ cytotoxic T lymphocytes and specific
antibody responses in vivo [53]. They further characterized
acidic pH effects using human DCs and found that the
transient exposure of human DCs to pH of 6.5 markedly
increases several costimulatory proteins and improves the
T-cell priming ability of DCs, which was associated with a
dramatic increase in p38MAK-dependent IL-12 production.
DC maturation by acidic pH stimulated the production of
IFN-𝛾, but not of IL-4, by antigen-specific CD4+ T cells.
These results suggest that extracellular acidification may
contribute to the initiation of adaptive immune responses
by DCs, favoring the development of the Th1 phenotype in
humans [54].
Basu and Srivastava suggested that TRPV1 is expressed in
mouse DCs and involved in their maturation [55]. However,
the role of TRPV1 is controversial. TRPV1 expression was
not confirmed and either capsaicin or acidic pH failed
to elicit a change in [Ca2+]i or the membrane current in
mouse DCs [56]. Recent studies have shown that TRPV1 is
expressed in human DCs; however, in this case, the channel
seems to inactivate rather than activate their maturation
[57]. The role of ASICs has also been suggested [58]. ASIC1,
ASIC2, and ASIC3 are expressed in mouse DCs, and selective
inhibitors for ASICs, such as amiloride and nonsteroidal
anti-inflammatory drugs (NSAIDs), inhibited acidic pH 6.5-
induced expression of cell-surface molecules CD11c, MHC
class II, CD80, and CD86.
We have recently examined the role of proton-sensing
GPCRs in DC functions [59]. Mouse DCs express OGR1-
family receptors, including OGR1; the functional expression
of OGR1 was confirmed by the extracellular acidic pH-
and OGR1-dependent increase in [Ca2+]i. OVA-sensitized
DCs from OGR1-deficient mice showed the reduction in the
expression of CCR7, a chemokine receptor for mature DCs,
and the migration responses to CCL19 and CCL21, ligands
for CCR7, as compared with those from wild-type mice [59].
Thus, OGR1 seems to be functioning in themigratory process
of DCs to draining lymph nodes (see the next section).
4. Role of Proton-Sensing Channels
and OGR1-Family GPCRs in Asthma Models
Although the contribution of TRPV1 to acidic pH-induced
cough and bronchoconstriction is well demonstrated as
discussed, it remains to be proven whether TRPV1-mediated
neurogenic inflammation plays a central role in asthma
and other respiratory diseases. The inarticulate conclusion
is based on the lack of obvious effects by gene targeting
experiments; TRPV1 deficiency did not attenuate or rather
enhanced the airway inflammation and AHR as induced
by LPS [60], antigens [61, 62], and cigarette smoke [63]
in TRPV1 knockout mice. The anti-inflammatory role of
TRPV1 might be, in part, explained by the release of anti-
inflammatory somatostatin from the sensory nerve terminals
in response to TRPV1 stimulation [60]. Regardless, the role
of TRPV1 in the airway inflammation and AHR remains
to be established in mice. However, uncertain results with
mice may be partly explained by the strain difference:
the previous studies [60–63] used C57BL/6. Rehman et
al. [64] have recently shown that TRPV1 knockdown with
siRNA attenuates IL-13- and antigen-induced asthmatic fea-
tures including airway inflammation and AHR in Balb/c
mice.
In addition to proton-sensing channels, proton-sensing
GPCRs also play an important role in the pathophysiology
of asthma. As described above, Kottyan et al. have shown
that TDAG8 deficiency causes the stimulation of eosinophil
apoptosis and, thereby, reduces airway eosinophilia in OVA-
and Aspergillus fumigatus-sensitization models of mice in
vivo [45]. They have also shown increased expression of
TDAG8 in lungs from OVA-sensitized mice and in nasal
brushing samples from pediatric asthma patients. Unfortu-
nately, whether AHR and airway inflammation as cardinal
features of asthma are modulated by TDAG8 in vivo has not
been examined; however, it is noted that IL-13 production,
which plays a role in these processes, was not affected by
TDAG8 deficiency [45].
The findings of the expression of proton-sensingOGR1 in
DC, a critical cell for antigen recognition and its presentation
to T cells, and the involvement of OGR1 in the DCmigration
process [59] suggest participation of OGR1 in the pathophys-
iology of allergic asthma. Indeed, OGR1-deficient mice are
resistant to the cardinal features of asthma, including airway
eosinophilia, AHR, and goblet cell metaplasia, in association
with a remarkable inhibition of the production of Th2
cytokines, including IL-4, IL-5, and IL-13, and OVA-specific
IgE in an OVA-induced asthma model [59]. Intratracheal
transfer to wild-type mice of OVA-primed bone marrow-
derived DCs from OGR1-deficient mice developed lower
AHR and eosinophilia as compared with the transfer of those
fromwild-typemice, which was associated with lowermigra-
tory activity to the peribronchial lymph nodes in OGR1-
deficient DCs than in wild-type DCs. These results suggest
that stimulation of OGR1 on DCs is critical for the early
processes, that is, migration to lymph nodes and initiation of
Th2 polarization, and, thereby, induces eosinophilia, airway
inflammation, and AHR [59]. Since OGR1 is expressed in
structural cells, including ASM cells and epithelial cells, and
functions in a variety of cell-specific responses, the reduction
of AHR and goblet hyperplasia in OGR1-deficient mice may
be partly attributed to the reduction of acidification-induced
constriction of ASM cells [35, 36] and mucin production in
epithelial cells [40].
Finally, it should be noted that acidic pH modulates DCs
leading to Th1 polarization in humans as described [51],
which contrasts with the role of OGR1 in Th2 polarization
in mice. The reason for the difference in the fate of T cells,
that is, Th1 or Th2, is currently unknown. DCs express
proton-sensing GPCRs other than OGR1, and OGR1-family
GPCRs are expressed in neutrophils and macrophages as
well. Therefore, differences in experimental conditions, for
example, species, stimulants, antigens, and pH, may modify
the state of DC activation and DC-T cell interaction, making
näıve T cells polarize to Th1, Th2, Th17, or other phenotypes.
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How change in the pH microenvironment modulates DC
function and T cell polarization warrants further study.
5. Conclusions
Proton-sensing channels, such as TRPV1 and ASICs, and
OGR1-family GPCRs are expressed in structural cells, includ-
ing ASM cells and epithelial cells, and inflammatory and
immune cells, including eosinophils and DCs, and play
a variety of roles in airway responses, depending on the
optimum pH of proton-sensing channels and GPCRs. Cough
and bronchoconstriction are activated by severe acidic pH
of 4 to 5 and are mainly mediated by pH-sensing channels
through sensory neurons, although pH-sensing OGR1 on
ASM cells may also be involved in the cell constriction. At
mild alkaline or mild acidic pH of more than 6, however,
OGR1-family GPCRs may be the main receptors involved in
the regulation of airway responses under pathophysiological
situations, such as allergic asthma. Thus, ionotropic and
metabotropic proton-sensing receptors may be therapeutic
targets for inflammatory and ischemic diseases, such as
asthma, for which drugs that aremore specific and have fewer
side effects are still required.
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